[1]马丽丽a,刚　君b,吕　静.妊娠并发甲减患者血清脂蛋白相关磷脂酶A2水平与母婴预后的相关性分析[J].现代检验医学杂志,2021,36(06):183-187.[doi:10.3969/j.issn.1671-7414.2021.06.040]
　MA Li-Li,Lü Jing,GANG Jun.Correlation between Serum Lipoprotein Associated Phospholipase A2 Level and Maternal and Infant Prognosis in Pregnant Women with Hypothyroidism[J].Journal of Modern Laboratory Medicine,2021,36(06):183-187.[doi:10.3969/j.issn.1671-7414.2021.06.040]
点击复制

妊娠并发甲减患者血清脂蛋白相关磷脂酶A2水平与母婴预后的相关性分析()
分享到：

《现代检验医学杂志》[ISSN:/CN:]

卷:
第36卷
期数:
2021年06期
页码:
183-187
栏目:
检验与临床
出版日期:
2021-12-15

文章信息/Info

Title:
Correlation between Serum Lipoprotein Associated Phospholipase A2 Level and Maternal and Infant Prognosis in Pregnant Women with Hypothyroidism
文章编号:
1671-7414（2021）06-183-06
作者:
马丽丽1a; 刚　君1b; 吕　静2
（1.北京市大兴区人民医院a.妇产科；b.科教科，北京102600；2.首都医科大学密云教学医院妇产科，北京101500）
Author(s):
MA Li-Li;  Lü Jing;  GANG Jun
（1a.Department of Obstetrics and Gynecology;1b.Department of Science and Education,Daxing District People’s Hospital of Beijing City,Beijing 102600, China;2.Department of Obstetrics and Gynecology,Miyun Teaching Hospital of Capital Medical University,Beijing 101500,China）
关键词:
妊娠并发甲状腺功能减退; 脂蛋白相关磷脂酶A2; 母婴结局
分类号:
R714.256；R446.112
DOI:
10.3969/j.issn.1671-7414.2021.06.040
文献标志码:
A
摘要:
目的　探讨血清脂蛋白相关磷脂酶A2（LP-PLA2）水平在妊娠并发甲减患者中的表达，并分析其与母婴预后的关系。方法　选取2018年7月~2020年7月妊娠并发甲减患者105例作为研究对象，其中妊娠并发临床甲减46例作为临床甲减组，妊娠并发亚临床甲减59例作为亚临床甲减组，另选取同期产检健康者50例作为对照组。采用酶联免疫吸附法检测血清LP-PLA2水平，采用全自动生化分析仪检测血清三酰甘油（TG）、总胆固醇（TC）、低密度脂蛋白胆固醇（LDL-C）和高密度脂蛋白胆固醇（HDL-C）水平，并记录母婴结局。采用Pearson检验分析妊娠并发甲减患者血清LP-PLA2与血脂水平的相关性；采用ROC曲线分析血清LP-PLA2及血脂水平对妊娠并发甲减患者母婴不良结局的预测价值。结果　三组患者血清LP-PLA2，TG，TC和LDL-C和HDL-C水平比较，差异均有统计学意义（F=31.177，97.170，18.242，25.286和9.423，均P＜0.05）；血清LP-PLA2，TG，TC，LDL-C水平由高到低为临床甲减组、亚临床甲减组、对照组，血清HDL-C水平由高到低为对照组、亚临床甲减组、临床甲减组，两两比较差异均有统计学意义（均P＜0.05）。妊娠并发甲减患者血清LP-PLA2与TG，TC，LDL-C水平均呈正相关（r=0.504，0.481和0.552，均P＜0.05），与HDL-C水平呈负相关（r=-0.433，P＜0.05）。亚临床甲减组和临床甲减组患者总母婴不良结局发生率分别为69.49%和78.26%，均明显高于对照组（32.00%）,差异有统计学意义（均P＜0.05）。母婴不良结局组患者血清LP-PLA2，TG，TC和LDL-C水平均明显高于母婴正常结局组（t=4.389，4.072，2.662，3.099，均P＜0.05），血清HDL-C水平明显低于母婴正常结局组（t=3.131，P＜0.05）。血清LP-PLA2水平预测妊娠并发甲减患者母婴不良结局的价值（曲线下面积0.942，敏感度和特异度分别为85.50%和96.40%）高于血脂指标。结论　妊娠并发甲减患者血清LP-PLA2水平升高，可作为评估母婴不良结局的血清指标。
Abstract:
Objective　To investigate the expression of serum lipoprotein associated phospholipase A2 (Lp-PLA2) in pregnant women with hypothyroidism and analyze its relationship with the prognosis of mother and infant. Methods　A total of 105 cases of pregnant women with hypothyroidism from July 2018 to July 2020 were selected as the research objects, including 46 cases of pregnant women with hypothyroidism as the clinical hypothyroidism group, 59 cases of pregnant women with subclinical hypothyroidism as the subclinical hypothyroidism group, and 50 healthy persons in the same period were selected as the control group. The level of serum Lp-PLA2 were detected by enzyme-linked immunosorbent assay. The levels of serum triglyceride (TG), total cholesterol (TC), low density lipoprotein cholesterol (LDL-C) and high density lipoprotein cholesterol (HDL-C) were detected by automatic biochemical analyzer. Pearson test was used to analyze the correlation between serum Lp-PLA2 and blood lipid levels in patients with Pregnancy complicated with hypothyroidism. ROC curve was used to analyze the predictive value of serum Lp-PLA2 and blood lipid levels in the adverse outcomes of pregnant women ard infants with hypothyroidism. Results　There were significant differences in serum Lp-PLA2, TG, TC, LDL-C and HDL-C levels among the three groups (F = 31.177, 97.170, 18.242, 25.286 and 9.423, all P < 0.05). Serum Lp-PLA2, TG, TC, LDL-C levels from high to low were in clinical hypothyroidism group, subclinical hypothyroidism group and control group, while serum HDL-C level from high to low was in control group, subclinical hypothyroidism group and clinical hypothyroidism group, with statistical significance (P < 0.05). Serum Lp-PLA2 was positively correlated with TG, TC, LDL-C levels ( r = 0.504, 0.481 and 0.552, all P < 0.05), and negatively correlated with HDL-C level in pregnant women with hypothyroidism ( r = -0.433, P < 0.05). The incidence of adverse maternal and infant outcomes in subclinical hypothyroidism group and clinical hypothyroidism group were 69.49% and 78.26%, respectively, which were significantly higher than that in the control group,the differences were stafisti significant-cally(P < 0.05). The levels of serum Lp-PLA2, TG, TC and LDL-C in the group with adverse maternal and infant outcomes were significantly higher than those in the group with normal maternal and infant outcomes ( t = 4.389, 4.072, 2.662, 3.099, all P< 0.05), and the level of serum HDL-C was significantly lower than that in the group with normal maternal and infant outcomes (t = 3.131, P < 0.05). The value of serum Lp-PLA2 level in predicting adverse maternal and neonatal outcomes of pregnant women with hypothyroidism (area under curve: 0.942, sensitivity and specificity were 85.50%, 96.40%,respectively) was higher than that of blood lipid index. Conclusion　The serum Lp-PLA2 level in pregnant women with hypothyroidism was increased, which can be used as a serum index to evaluate the adverse outcomes of mother and infant.

参考文献/References:

[1] GUTVIRTZ G, WALFISCH A, WAINSTOCK T,et al. Maternal hypothyroidism and future pediatricneurological morbidity of the offspring[J]. Archives ofGynecology and Obstetrics, 2019, 299(4): 975-981.
[2] SHRESTHA A, TRIPATHI P, DONGOL A. Pregnancyoutcomes in patients with hypothyroidism[J].Kathmandu University Medical Journal, 2019, 17(65):57-60.
[3] KIM M, YOO H J, LEE D, et al. Oxidized LDL inducesprocoagulant profiles by increasing lysophosphatidylcholinelevels, lysophosphatidylethanolamine levels, and Lp-PLA(2)activity in borderline hypercholesterolemia[J]. Nutrition,Metabolism, and Cardiovascular Diseases, 2020, 30(7):1137-1146.
[4] HERIANSYAH T, NAFISATUZZAMRUDAH N, AINIF N, et al. Reduction in vasa vasorum angiogenesisby Lp-PLA2 selective inhibitor through the HIF-1αand VEGF expression under dyslipidemic conditionsin atherosclerosis pathogenesis[J]. Cardiovascular &Hematological Agents in Medicinal Chemistry, 2018,16(2): 114-119.
[5] 李薇薇，李惠勉．缺血性脑卒中合并亚甲减血清TSH水平与TNF-α、Lp-PLA2、IL-6 水平的相关性分析[J]．中华神经医学杂志, 2019, 18(11):1124-1130.LI Weiwei, LI Huimian. Correlations of serum levelof thyroid-stimulating hormone with tumor necrosisfactor-α, lipoprotein associated phospholipase A2 andinterleukine-6 levels in ischemic stroke patients withsubclinical hypothyroidism [J]. Chinese Journal ofNeuromedicine, 2019, 18(11):1124-1130.
[6] 中华医学会内分泌学分会，中华医学会围产医学分会. 妊娠和产后甲状腺疾病诊治指南[J]．中华内分泌代谢杂志，2012，28（5）：354-371．Chinese Society of Endocrinology, Chinese MedicalAssociation, Chinese Society of Perinatology, ChineseMedical Association.Guideline on diagnosis andmanagement of thyroid diseases during Pregnancy andpostpartum [J]. Chinese Journal of Endocrinology andMetabolism, 2012, 28(5):354-371.
[7] SENESE R, CIOFFI F, PETITO G, et al. Thyroidhormone metabolites and analogues[J]. Endocrine,2019, 66(1): 105-114.
[8] SINHA R A, SINGH B K, YEN P M. Direct effectsof thyroid hormones on hepatic lipid metabolism[J].Nature Reviews Endocrinology, 2018, 14(5): 259-269.
[9] DELITALA A P, SCUTERI A, MAIOLI M, et al.Subclinical hypothyroidism and cardiovascular riskfactors[J]. Minerva Medica, 2019, 110(6): 530-545.
[10] 陈春梅，刘佳，贾育梅，等．甲状腺功能正常人群血清促甲状腺激素水平与血脂的相关性[J]．中国心血管杂志, 2020, 25(1):45-49.CHEN Chunmei, LIU Jia, JIA Yumei, et al. Correlationbetween serum thyroid-stimulating hormone and bloodlipid in subjects with normal thyroid function [J].Chinese Journal of Cardiovascular Medicine, 2020,25(1):45-49.
[11] LISOWSKA-MYJAK B, PUCHALSKA A, HA?ASAN, et al. The association between clinical and laboratoryparameters in thyroid disease and nonthyroidal illnessin young women[J]. European Review for Medical andPharmacological Sciences, 2019, 23(7): 2950-2959.
[12] 路春梅，齐俊巧，杨旭，等．妊娠期妇女甲状腺功能的筛查情况及相关影响因素分析[J]．现代生物医学进展，2020，20（20）：3983-3987．LU Chunmei, QI Junqiao, YANG Xu, et al. Analysisof thyroid function screening in pregnant women andrelated influencing factors [J]. Progress in ModernBiomedicine, 2020, 20(20):3983-3987.
[13] HUANG Fubao, WANG Kai, SHEN Jianhua.Lipoprotein‐associated phospholipase A2: the storycontinues[J]. Medicinal Research Reviews, 2020,40(1): 79-134.
[14] YANG Ming, WANG Anxin, LI Jiejie, et al. Lp-PLA(2)and dual antiplatelet agents in intracranial arterialstenosis[J]. Neurology, 2020, 94(2): e181-e189.
[15] 马利军，屈晓威，邢延芳，等．血清Lp-PLA2, IMA和LDL-C 水平检测与TCD 联合检查在缺血性脑血管病早期诊断中的价值[J]．现代检验医学杂志,2019, 34(4):103-107.MA Lijun, QU Xiaowei, XING Yanfang, et al. Valueof detection of serum Lp-PLA2,IMA and LDL-C leveland combined TCD in early diagnosis of ischemiccerebrovascular disease [J]. Journal of ModernLaboratory Medicine, 2019, 34(4):103-107.
[16] 王晶，东星，张学军，等．血清及胎盘中脂蛋白相关磷脂酶A2 水平与妊娠期高血压疾病的关系[J]．武警医学，2020，31（9）：805-808．WANG Jing, DONG Xing, ZHANG Xuejun, et al.Relationship of Lp-PLA2 levels in maternal serum andplacenta with hypertensive disorder of pregnancy [J].Medical Journal of the Chinese People’s Armed PoliceForces, 2020, 31(9):805-808.
[17] 国春蕾，姚水平，李宁．血清Nesfatin-1 及炎性因子水平对妊娠期糖尿病的早期临床预测价值[J]．现代免疫学, 2020, 40(5):391-395，407.GUO Chunlei, YAO Shuiping, LI Ning. Early clinicalpredictive value of nesfatin-1 and inflammatorycytokines in gestational diabetes mellitus [J]. CurrentImmunology, 2020, 40(5):391-395，407.
[18] XIAO Wei, YANG Yi, SHI Jiao, et al. The diagnosticefficacy and predictive value of combined lipoproteinlaboratory indexes for atherosclerosis[J].TheJournal of the Pakistan Medical Association,2020,70special(9):115-119.
[19] JACKISCH L, KUMSAIYAI W, MOORE J D, et al.Differential expression of Lp-PLA2 in obesity and type2 diabetes and the influence of lipids[J]. Diabetologia,2018, 61(5): 1155-1166.
[20] 李薪，魏力强．2 型糖尿病患者血清中脂蛋白相关磷脂酶A2 检测的临床意义[J]．现代检验医学杂志,2017, 32(6):85-88.LI Xin, WEI Liqiang. Clinical significance of detectionof lipoprotein associated phospholipase A2 in serumof patients with type 2 diabetes mellitus [J]. Journal ofModern Laboratory Medicine, 2017, 32(6):85-88.
[21] 韩媛，王爽，黄超，等．急性缺血性脑卒中患者血清Lp-PLA2 与HCY、hsCRP 及生化指标的相关性分析[J]．中华急诊医学杂志, 2019, 28(8):1026-1028.HAN Yuan, WANG Shuang, HUANG Chao, et al.Correlation analysis of serum Lp-PLA2 with HCY,hsCRP and biochemical indexes in patients with acuteischemic stroke[J]. Chinese Journal of EmergencyMedicine, 2019, 28(8):1026-1028.
[22] 卫华，段思柳，冯香艳，等．妊娠期糖尿病患者产后血清相关细胞因子与糖代谢异常的关系[J]．中国计划生育学杂志，2018，26（9）：837-840．WEI Hua, DUAN Siliu, FENG Xiangyan, et al.Relationship between postpartum serum relatedcytokines and abnormal glucose metabolism of patientswith gestational diabetes [J]. Chinese Journal of FamilyPlanning, 2018, 26(9):837-840.

相似文献/References:

[1]洪骏,王锋,印中鹏,等.冠心病患者血浆纤维蛋白原与脂蛋白相关磷脂酶A2水平[J].现代检验医学杂志,2015,30(05):6.[doi:10.3969/j.issn.1671-7414.2015.05.003]
　HONG Jun,WANG Feng,YIN Zhong-peng,et al.Levels of Plasma Lipoprotein Associated Phospholipase A2 and Fibrinogen in Patients with Coronary Artery Disease[J].Journal of Modern Laboratory Medicine,2015,30(06):6.[doi:10.3969/j.issn.1671-7414.2015.05.003]
[2]姚创利,赵 佳,鲁旭娟,等.冠心病患者血清脂蛋白相关磷脂酶A2水平与锰超氧化物歧化酶9 Ala/Val基因多态性关系探讨[J].现代检验医学杂志,2017,32(01):26.[doi:10.3969/j.issn.1671-7414.2017.01.008]
　YAO Chuang-li,ZHAO Ja,LU Xu-juan,et al.Study on the Relationship between Lipoprotein Associated Phospholipase A2 Level and Manganese Superoxide Dismutase 9 Ala/Val Genetic Polymorphism in Patients with Coronary Heart Disease[J].Journal of Modern Laboratory Medicine,2017,32(06):26.[doi:10.3969/j.issn.1671-7414.2017.01.008]
[3]文关良,剌 梅.脂蛋白相关磷脂酶A2在颈动脉斑块性脑梗死中的临床意义[J].现代检验医学杂志,2017,32(02):117.[doi:10.3969/j.issn.1671-7414.2017.02.032]
　WEN Guan-liang,LA Mei.Clinical Study of LP-PLA2 in Carotid Plaques Cerebral Infarction Patients[J].Journal of Modern Laboratory Medicine,2017,32(06):117.[doi:10.3969/j.issn.1671-7414.2017.02.032]
[4]王 坤,贾兴旺,董 矜,等.血清脂蛋白相关磷脂酶A2和胱抑素C联合检测对SLE患者并发狼疮性肾炎的风险评估[J].现代检验医学杂志,2017,32(04):6.[doi:10.3969/j.issn.1671-7414.2017.04.002]
　WANG Kun,JIA Xing-wang,DONG Jin,et al.Risk Assessment of Combined Detection of Lipoprotein Associated Phospholipase A2 and Cystatin C for Lupus Nephritis in Patients with Systemic Lupus Erythematosus[J].Journal of Modern Laboratory Medicine,2017,32(06):6.[doi:10.3969/j.issn.1671-7414.2017.04.002]
[5]李 薪,魏力强.2型糖尿病患者血清中脂蛋白相关磷脂酶A2检测的临床意义[J].现代检验医学杂志,2017,32(06):85.[doi:10.3969/j.issn.1671-7414.2017.06.001]
　LI Xin,WEI Li-qiang.Clinical Significance of Detection of Lipoprotein Associated Phospholipase A2 in Serum of Patients with Type 2 Diabetes Mellitus[J].Journal of Modern Laboratory Medicine,2017,32(06):85.[doi:10.3969/j.issn.1671-7414.2017.06.001]
[6]王丹晨,侯立安,国秀芝,等.改良后的长春恒晓脂蛋白相关磷脂酶A2活性检测试剂性能验证[J].现代检验医学杂志,2018,33(04):134.[doi:10.3969/j.issn.1671-7414.2018.04.037]
　WANG Dan-chen,HOU Li-an,GUO Xiu-zhi,et al.Performance Verification of Improved Lipoprotein-associated Phospholipase A2 Detection Reagent of Changchun Hengxiao Co.,Ltd.[J].Journal of Modern Laboratory Medicine,2018,33(06):134.[doi:10.3969/j.issn.1671-7414.2018.04.037]
[7]张东方,王 茜,李 娟,等.高龄妊娠期糖尿病患者血清miR-351，FGF19 和LP-PLA2 表达水平及其与产后糖代谢异常的相关性研究[J].现代检验医学杂志,2023,38(01):66.[doi:10.3969/j.issn.1671-7414.2023.01.013]
　ZHANG Dong-fang,WANG Qian,LI Juan,et al.Serum miR-351, FGF19 and LP-PLA2 Expression Levels in Elderly Patients with Gestational Diabetes Mellitus and Their Correlation with Abnormal Postpartum Glucose Metabolism[J].Journal of Modern Laboratory Medicine,2023,38(06):66.[doi:10.3969/j.issn.1671-7414.2023.01.013]

备注/Memo

备注/Memo:
基金项目：2021年度慢性病防治与健康教育科研项目（编号：BJMB0012021025016）。作者简介：马丽丽（1977-），女，硕士研究生，副主任医师，主要从事高危妊娠方面研究，E-mail:mll13520728364@163-com。
更新日期/Last Update: 1900-01-01